|
[Related PubMed/MEDLINE] Total Number of Papers: 32
|
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of |
|
|
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2019 |
Bio- Fortification of Angelica gigas Nakai Nano-Powder Using Bio-Polymer by Hot Melt Extrusion to Enhance the Bioaccessibility and Functionality of Nutraceutical Compounds. |
AA, AGN, AGNC, DeltaH, DPPH, DSC, EAGN, FAGN, FRAP, FTIR, HME, HP, HPMC, Tg |
2 |
2019 |
Decursin and Decursinol Angelate Suppress Adipogenesis through Activation of beta-catenin Signaling Pathway in Human Visceral Adipose-Derived Stem Cells. |
ACC, ADM, AGN, ASCs, FAS, GSK, PPARgamma, VAT |
3 |
2019 |
Decursinol angelate ameliorates 12-O-tetradecanoyl phorbol-13-acetate (TPA) -induced NF-kappaB activation on mice ears by inhibiting exaggerated inflammatory cell infiltration, oxidative stress and pro-inflammatory cytokine production. |
TPA |
4 |
2019 |
Decursinol Angelate Ameliorates Dextran Sodium Sulfate-Induced Colitis by Modulating Type 17 Helper T Cell Responses. |
DSS, Th17 |
5 |
2019 |
Rapid and Efficient Separation of Decursin and Decursinol Angelate from Angelica gigas Nakai using Ionic Liquid, (BMIm)BF4, Combined with Crystallization. |
A. gigas, DW, ILs, RSM |
6 |
2018 |
Decursin and decursinol angelate: molecular mechanism and therapeutic potential in inflammatory diseases. |
--- |
7 |
2018 |
Decursinol Angelate Inhibits LPS-Induced Macrophage Polarization through Modulation of the NFkappaB and MAPK Signaling Pathways. |
iNOS, LPS, NOX, PMA |
8 |
2018 |
Development of Resveratrol-Loaded Herbal Extract-Based Nanocomposites and Their Application to the Therapy of Ovarian Cancer. |
NPs, RSV |
9 |
2018 |
Polydopamine-coated nanocomposites of Angelica gigas Nakai extract and their therapeutic potential for triple-negative breast cancer cells. |
NCs, PD, UV, XPS |
10 |
2018 |
Simultaneous Determination of Decursin, Decursinol Angelate, Nodakenin, and Decursinol of Angelica gigas Nakai in Human Plasma by UHPLC-MS/MS: Application to Pharmacokinetic Study. |
AGN |
11 |
2017 |
Fabrication of polymer matrix-free nanocomposites based on Angelica gigas Nakai extract and their application to breast cancer therapy. |
NCs |
12 |
2017 |
Natural Korean Medicine Dang-Gui: Biosynthesis, Effective Extraction and Formulations of Major Active Pyranocoumarins, Their Molecular Action Mechanism in Cancer, and Other Biological Activities. |
AGN, ROS |
13 |
2017 |
Prostate Cancer Xenograft Inhibitory Activity and Pharmacokinetics of Decursinol, a Metabolite of Angelica gigas Pyranocoumarins, in Mouse Models. |
AGN, AR, AUC, TRAMP |
14 |
2016 |
Decursinol angelate inhibits PGE2-induced survival of the human leukemia HL-60 cell line via regulation of the EP2 receptor and NFkappaB pathway. |
PGE2 |
15 |
2016 |
Nanocomposites based on Soluplus and Angelica gigas Nakai extract fabricated by an electrohydrodynamic method for oral administration. |
AGN, AGN, EHD, NCs, SP, XRD |
16 |
2016 |
Omega-3 fatty acids incorporated colloidal systems for the delivery of Angelica gigas Nakai extract. |
AGN, EXT, ME |
17 |
2016 |
Pyranocoumarin Tissue Distribution, Plasma Metabolome and Prostate Transcriptome Impacts of Sub-Chronic Exposure to Korean Angelica Supplement in Mice. |
AGN |
18 |
2015 |
Angelica gigas Nakai and Soluplus-Based Solid Formulations Prepared by Hot-Melting Extrusion: Oral Absorption Enhancing and Memory Ameliorating Effects. |
AGN, EXT, HME |
19 |
2015 |
Cancer Chemoprevention with Korean Angelica: Active Compounds, Pharmacokinetics, and Human Translational Considerations. |
AGN, PK |
20 |
2015 |
Chemopreventive Effects of Korean Angelica versus Its Major Pyranocoumarins on Two Lineages of Transgenic Adenocarcinoma of Mouse Prostate Carcinogenesis. |
AGN, DLP, NECA, TRAMP |
21 |
2015 |
Cytochrome P450 Isoforms in the Metabolism of Decursin and Decursinol Angelate from Korean Angelica. |
ABT, CES, HLM, PK |
22 |
2015 |
Single oral dose pharmacokinetics of decursin and decursinol angelate in healthy adult men and women. |
AGN |
23 |
2012 |
A synthetic decursin analog with increased in vivo stability suppresses androgen receptor signaling in vitro and in vivo. |
AR, DPTC, PCa, PSA |
24 |
2012 |
Anti-cancer and other bioactivities of Korean Angelica gigas Nakai (AGN) and its major pyranocoumarin compounds. |
AGN |
25 |
2012 |
Overexpression of cinnamate 4-hydroxylase gene enhances biosynthesis of decursinol angelate in Angelica gigas hairy roots. |
AgPAL, CaMV |
26 |
2012 |
Quantitative determination of decursin, decursinol angelate, and decursinol in mouse plasma and tumor tissue using liquid-liquid extraction and HPLC. |
LLOQ |
27 |
2011 |
Protective effects of decursin and decursinol angelate against amyloid beta-protein-induced oxidative stress in the PC12 cell line: the role of Nrf2 and antioxidant enzymes. |
AD |
28 |
2010 |
Decursinol angelate blocks transmigration and inflammatory activation of cancer cells through inhibition of PI3K, ERK and NF-kappaB activation. |
ECM, MMP |
29 |
2009 |
In vivo anti-cancer activity of Korean Angelica gigas and its major pyranocoumarin decursin. |
AGN, LLC |
30 |
2008 |
In vitro inhibitory potential of decursin and decursinol angelate on the catalytic activity of cytochrome P-450 1A1/2, 2D15, and 3A12 isoforms in canine hepatic microsomes. |
DC |
31 |
2007 |
Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells. |
ER |
32 |
2007 |
Transport of decursin and decursinol angelate across Caco-2 and MDR-MDCK cell monolayers: in vitro models for intestinal and blood-brain barrier permeability. |
BBB, De, Ly |
|